Churchill Capital Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Board of directors recommends stockholders and warrant holders vote "for" all proposals new york and altrincham, england , march 22, 2024 /prnewswire/ -- churchill capital corp vii ("churchill vii") (nasdaq: cvii), a special purpose acquisition company, announced today that it has scheduled a special meeting of churchill vii stockholders and a meeting of churchill vii warrant holders for may 21, 2024 in connection with the proposed business combination between corpacq holdings limited ("corpacq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and churchill vii (the "business combination"). the business combination continues to progress and is expected to be completed in the first half of 2024.

In excess of $605 million remains in churchill vii's trust account after stockholder redemptions relating to the extension new york , feb. 12, 2024 /prnewswire/ -- churchill capital corp vii ("churchill vii") (nasdaq: cvii) announced today that in a special meeting of its stockholders ("special meeting"), churchill vii's stockholders voted to approve a proposal to amend churchill vii's certificate of incorporation and extend the date by which churchill vii is required to consummate its initial business combination (the "business combination") with corpacq holdings limited ("corpacq") from february 17, 2024 to august 17, 2024 (or such earlier date as determined by the board of directors of churchill vii)...

Special meeting of stockholders of churchill vii scheduled for february 8, 2024 to extend date by which churchill vii must consummate its business combination with corpacq holdings limited new york , jan. 30, 2024 /prnewswire/ -- churchill capital corp vii ("churchill vii") announced today actions being undertaken in advance of a special meeting of its stockholders (the "special meeting") on february 8, 2024, at which churchill vii's stockholders will be asked to vote on, among other things, a proposal to amend churchill vii's amended and restated certificate of incorporation to extend the date by which churchill vii has to consummate its business combination with corpacq holdings limited ("corpacq") from february 17, 2024 to august 17, 2024 or such earlier date as determined by the churchill vii board of directors (the "board") (the "extension amendment proposal")...

New york , jan. 23, 2024 /prnewswire/ -- churchill capital corp vii ("churchill vii") (nyse: cvii), a special purpose acquisition company, announced today that it plans to transfer the listing of its shares of class a common stock, public warrants and public units from the new york stock exchange ("nyse") to nasdaq global market ("nasdaq"). churchill vii expects that listing and trading of its securities on the nyse will end at market close on february 2, 2024, and expects to commence trading as a nasdaq-listed company upon market open on february 5, 2024.

Altrincham, england and new york , jan. 22, 2024 /prnewswire/ -- corpacq holdings limited ("corpacq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today provided the following business update including: reaffirming guidance for the full year ending december 31, 2023; confirming on track timing of its business combination with churchill capital corp vii ("churchill vii") (nyse: cvii); a successful refinancing of its group debt; and upcoming analyst day.  management reaffirms financial outlook for full-year 2023  since the release of its financials for the first six months of 2023 on november 17, 2023, corpacq has continued to maintain its strong and profitable growth trajectory.